Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency (Kamada API)

This study has been completed.
Sponsor:
Information provided by:
Kamada, Ltd.
ClinicalTrials.gov Identifier:
NCT00460096
First received: April 12, 2007
Last updated: October 16, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Estimated Primary Completion Date: No date given
No publications provided by Kamada, Ltd.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):